Nuveen
DRUG

Nuveen’s Bright Minds Biosciences DRUG Stock Holding History

Nuveen’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
16,889
+8,560
+103% +$672K ﹤0.01% 2858
2026
Q1 		$608K Buy
8,329
+2,342
+39% +$189K ﹤0.01% 2768
2025
Q4 		$467K Sell
5,987
-6,500
-52% -$434K ﹤0.01% 2905
2025
Q3 		$757K Hold
12,487
– – ﹤0.01% 2746
2025
Q2 		$326K Buy
+12,487
New +$374K ﹤0.01% 3017

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Nuveen's DRUG Position: Q2 2026 in Review

Nuveen increased its Bright Minds Biosciences (DRUG) stake by 103% in Q2 2026, buying an estimated $672K and bringing the position to 16,889 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

Nuveen first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Nuveen held 16,889 shares of Bright Minds Biosciences worth $1.19M as of Q2 2026.
  • Nuveen bought 8,560 Bright Minds Biosciences shares in Q2 2026, an estimated $672K.
  • Bright Minds Biosciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2858 holding.
  • Nuveen first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.